Paper Review Records
全部论文审稿周期
13 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
52
天
Chromosomal instability does not correlate with metastatic potential in human cancer cell lines
作者
Greta Mühlmeier; Carolin Feldmann; Timothy Wohlfromm; Bianca N. Kraft; Alwin Krämer展开收起
作者单位
1. Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; 2. Center for Pediatrics and Adolescent Medicine, Hannover Medical School (MHH), Hannover, Germany; 3. Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany; 4. Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany展开收起
30
天
Prognostic value of preoperative circulating tumor DNA in non-small cell lung cancer: a systematic review and meta-analysis
作者
Jiamin Lu; Yuqian Feng; Kaibo Guo; Leitao Sun; Shanming Ruan; Kai Zhang展开收起
作者单位
1. The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China; 2. The First Affiliated Hospital of Zhejiang, Chinese Medical University, (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China; 3. Hangzhou TCM Hospital of Zhejiang Chinese Medical University, Hangzhou, China; 4. Department of Oncology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China; 5. Anji Traditional Chinese Medical Hospital, Huzhou, China展开收起
141
天
The effect of resistin on the redox state of breast cancer cells
作者
Elitsa Pavlova; Radoslav Stojchevski; Dimiter Avtanski展开收起
作者单位
1. Faculty of Physics, Sofia University “St. Kliment Ohridski”, Sofia, Bulgaria; 2. Friedman Diabetes Institute, Lenox Hill Hospital, Northwell Health, New York, USA; 3. Donald and Barbara Zucker School of Medicine at Hofstra, Northwell, Hempstead, USA; 4. Feinstein Institutes for Medical Research, Manhasset, NY, USA展开收起
55
天
Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis
作者
Jian Wang; Miaomiao Liu; Jiaxing Sun; Zifeng Zhang展开收起
作者单位
1. Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi’an, China; 2. Department of Respiratory, Tangdu Hospital, Fourth Military Medical University, Xi’an, China; 3. Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi’an, China展开收起
29
天
Hypofractionated versus standard chemoradiotherapy in the definitive treatment of uterine cervix cancer: interim results of a randomized controlled clinical trial
作者
Afsane Maddah Safaei; Ebrahim Esmati; Marzieh Gomar; Setareh Akhavan; Shahrzad Sheikh Hasani; Mona Malekzadeh Moghani; Narges Zamani; Maryam Moshtaghi; Mahrooz Malek; Fatemeh Jafari; Azadeh Sharifian; Kasra Kolahdouzan展开收起
作者单位
1. Radiation Oncology Research Center (RORC), Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran; 2. Department of Obstetrics and Gynecology, Vali-Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran; 3. Department of Oncologic Gynecology, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran; 4. Department of Radiation Oncology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 5. Radiation Oncology Department, Booali Hospital, Tehran, Iran; 6. Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Radiology Department, Imam Khomeini Hospital Complex (IKHC), Tehran University of Medical Sciences, Tehran, Iran展开收起
65
天
Predictive biomarkers for immunotherapy response in extensive-stage SCLC
作者
Lin Zhu; Jing Qin展开收起
作者单位
1. Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China; 2. Zhejiang Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology (Lung and Esophagus), Zhejiang Cancer Hospital, Hangzhou, People’s Republic of China展开收起
FAQ
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY审稿要多久?
截至2026-11-19,CrushSCI 收录了 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 的 13 篇完整审稿记录。最快一篇从收稿到录用用了 19 天(Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017,2023-10-26 收稿,2023-11-14 录用),最慢一篇用了 203 天;平均 71.5 天,中位数 55 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
